該当箇所へ

Immatics Uses Genedata Biologics for Novel T Cell Receptor-Based Immunotherapy R&D

Instead of embarking on a costly and time-consuming software customization project, Immatics uses Genedata’s out-of-the-box functionality to streamline CGT processes and increase R&D efficiency. Genedata’s scientific consultants worked closely with Immatics to configure Immatics-specific CGT workflows and integrate laboratory instruments so rollout of the platform was straightforward – and fast.